NCT06549361View on ClinicalTrials.gov

A Retrospective Study on Extranodal DLBCL

CompletedOBSERVATIONAL
Enrollment

5,023

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

September 1, 2023

Conditions
LymphomaExtranodal LymphomaDiffuse Large B Cell Lymphoma
Interventions
OTHER

No interventions need to be specified for this study

No interventions need to be specified for this study

Trial Locations (1)

200000

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER